BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9177383)

  • 1. Studies of the impact of a liver glucokinase promoter variant on glucose tolerance and insulin sensitivity index.
    Urhammer SA; Hansen T; Jensen LB; Clausen JO; Hansen L; Chui KC; Pedersen O
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1786-9. PubMed ID: 9177383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
    Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M
    Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant.
    Yamada K; Yuan X; Ishiyama S; Ichikawa F; Koyama KI; Koyanagi A; Koyama W; Nonaka K
    Diabetes Care; 1997 Jul; 20(7):1159-61. PubMed ID: 9203455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus.
    Chiu KC; McCarthy JE
    Biochem Biophys Res Commun; 1996 Apr; 221(3):614-8. PubMed ID: 8630009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.
    Stone LM; Kahn SE; Fujimoto WY; Deeb SS; Porte D
    Diabetes; 1996 Apr; 45(4):422-8. PubMed ID: 8603762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance.
    Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS
    Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus.
    Shimokawa K; Sakura H; Otabe S; Eto K; Kadowaki H; Hagura R; Yazaki Y; Akanuma Y; Kadowaki T
    J Clin Endocrinol Metab; 1994 Sep; 79(3):883-6. PubMed ID: 8077376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance.
    Tschritter O; Machicao F; Stefan N; Schäfer S; Weigert C; Staiger H; Spieth C; Häring HU; Fritsche A
    J Clin Endocrinol Metab; 2006 Feb; 91(2):654-8. PubMed ID: 16317062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women.
    Zaidi FK; Wareham NJ; McCarthy MI; Holdstock J; Kalloo-Hosein H; Krook A; Swinn RA; O'Rahilly S
    Diabet Med; 1997 Mar; 14(3):228-34. PubMed ID: 9088772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population.
    Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG
    Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion.
    Rose CS; Andersen G; Hamid YH; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T
    Diabet Med; 2005 Jul; 22(7):946-9. PubMed ID: 15975113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance.
    Almind K; Frederiksen SK; Ahlgren MG; Urhammer S; Hansen T; Clausen JO; Pedersen O
    Diabetologia; 1998 Aug; 41(8):969-74. PubMed ID: 9726601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus.
    März W; Nauck M; Hoffmann MM; Nagel D; Boehm BO; Koenig W; Rothenbacher D; Winkelmann BR
    Circulation; 2004 Jun; 109(23):2844-9. PubMed ID: 15173029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men.
    McCarthy MI; Hitman GA; Hitchins M; Riikonen A; Stengård J; Nissinen A; Tuomilehto-Wolf E; Tuomilehto J
    Diabet Med; 1994 Mar; 11(2):198-204. PubMed ID: 8200207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucokinase gene variations in Japanese-Americans with a family history of NIDDM.
    Stone LM; Kahn SE; Deeb SS; Fujimoto WY; Porte D
    Diabetes Care; 1994 Dec; 17(12):1480-3. PubMed ID: 7882822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
    Amoah AG; Owusu SK; Schuster DP; Osei K
    S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort.
    Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N
    Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
    Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the hormone sensitive lipase -60C > G variant with fasting insulin levels in healthy young men.
    Talmud PJ; Palmen J; Nicaud V; Tiret L;
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):173-7. PubMed ID: 12514936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity.
    Haupt A; Guthoff M; Schäfer SA; Kirchhoff K; Machicao F; Gallwitz B; Staiger H; Stefan N; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2009 May; 94(5):1775-80. PubMed ID: 19258404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.